-
Appendix 3Y (x2)
24 December 2008
Change of Director's Interest Notice
-
Appendix 3B
23 December 2008
New issue announcement, application for quotation of additional securities and agreement
-
Appendix 3B
10 December 2008
New issue announcement, application for quotation of additional securities and agreement
-
AutoStart Burette Update
10 December 2008
Analytica wishes to advise that it has today shipped samples of its AutoStart® Burette to two leading overseas multi-national manufacturers and suppliers of infusion pumps and burettes.
-
Letter to Optionholders
05 December 2008
Analytica wishes to advise that it has today written to the holders of $0.02 options which expire on 31 December 2008 to advise them on how they may exercise their holding of options. Accompanying the letter is an Option Exercise form, an AutoStart® Burette product brochure and a DVD demonstrating the performance of the AutoStart® Burette. Both the AutoStart® Burette video and product brochure can be accessed via the 'Products' page on the Analytica website, www.analyticamedical.com.
-
Option Exercise Form
01 December 2008
Analytica Limited wishes to advise option holders of the procedure to be followed when exercising unlisted options. An Option Exercise Form for options expiring 31 December 2008 is attached to this notice.
-
Appendix 3B
01 December 2008
New issue announcement, application for quotation of additional securities and agreement.
-
Correction to Appendix 3Y
01 December 2008
Analytica wishes to advise that the Appendix 3Y, lodged in relation to Mr. Ross Mangelsdorf on 28 November 2008 contained a typographical error. The notice incorrectly stated that Mr. Mangelsdorf had been issued 10,000,000 unlisted options. The correct number was 3,000,000. A corrected Appendix 3Y is attached.
-
Appendix 3B
28 November 2008
New issue announcement, application for quotation of additional securities and agreement
-
Appendix 3Y
28 November 2008
Change of Director?s Interest Notice
-
Operational Update to Annual General Meeting
26 November 2008
Analytica Limited is pleased to attach the following Operational Update which will be presented to the Annual General Meeting of the Company, commencing at 10:00am today (Brisbane time)
-
Results of Annual General Meeting
26 November 2008
We wish to advise that all resolutions put to the Annual General Meeting of Analytica Limited held today were passed on a show of hands
-
Chairman?s Address to Annual General Meeting
26 November 2008
-
Correction to New Zealand Austostart Burette Announcement
21 November 2008
Analytica wishes to advise that the announcement lodged with ASX on Thursday 20 November 2008 ("Release of AutoStart Burette in New Zealand") contained an error.
-
Release of AutoStart® Burette for sale in New Zealand
20 November 2008
-
Release of AutoStart® Burette for sale in Australia
18 November 2008
Analytica Ltd is pleased to announce that its AutoStart® Burette has passed all required biological and chemical tests and has now been released for sale in Australia.
-
Notice of Annual General Meeting
27 October 2008
The Annual General Meeting of Analytica Ltd will be held at 10:00am (Brisbane time) Wednesday 26 November 2008 at the BTP Technology and Conference Centre, Brisbane Technology Park, 1 Clunies Ross Court, Eight Mile Plains.
-
Appendix 4C - Quarterly Cash Flow
27 October 2008
Analytica Ltd presents its Appendix 4C for the quarter ended 30 September 2008 and an update on developments in the Company.
-
Appointment of Director
7 October 2008
Analytica Limited is pleased to announce the appointment of Mr. Ross Mangelsdorf as a Non-executive director.
-
Corporate Governance Charter
14 October 2008
-
Appendix 3X - Initial Director?s Interest Notice
7 October 2008
-
Appendix 3B - New issue announcement.
7 October 2008
-
Annual Report for the year ended 30 June 2008
12 September 2008
-
Retractable Technology Update
10 September 2008
Analytica Limited is pleased to update the market on the progress which has been made in relation to its retractable technology.
-
Appendix 4E - Preliminary Final Report
29 August 2008
-
Adoption of Corporate Governance Charter
15 August 2008
Analytica Ltd is pleased to announce that it has adopted a new Corporate Governance Charter, a copy of which is attached to this announcement.
The Company recently undertook a review of it?s corporate governance practices and has adopted a Charter which reflects current best practice in this regard.
-
Appendix 4C - Quarterly Cash Flow
30 July 2008
Analytica Ltd presents its Appendix 4C for the quarter ended 30 June 2008 and an update on developments in the Company.
-
Application for Patent for a Flushable Burette Injection Port
1 July 2008
Analytica today announced that it has applied for a patent (AU 2008903153) for the inclusion of a needle-less injection port on its AutoStart burette. This important enhancement will allow both the injection site and the syringe administering the medication into the AutoStart burette to be easily flushed using fluid from the IV bag, rather than using additional swabs and saline vials.
-
Appendix 3B
20 June 2008
Appendix 3B - New issue announcement, application for quotation of additional securities and agreement
-
Correction to Appendix 3B
19 June 2008
The Appendix 3B lodged by the Company on 19 June contained a typographical error in relation to the number of shares currently on issue. The correct number of shares now on issue is 278,773,572. A revised Appendix 3B is attached.
-
Appendix 3B
19 June 2008
Appendix 3B - New issue announcement, application for quotation of additional securities and agreement
-
Form 605
21 May 2008
Notice of ceasing to be a substantial holder - Viralytics Limited
-
Form 604
2 May 2008
Notice of change of interests of substantial holder - Viralytics Limited
-
Appendix 4C - Quarterly Cash Flow
30 April 2008
Analytica Ltd presents its Appendix 4C for the quarter ended 31 March 2008 and an update on developments in the Company.
-
Form 604
7 April 2008
Notice of change of interests of substantial holder - Viralytics Limited
-
Change of Contact Details
19 March 2008
Analytica Limited wishes to announce that its telephone and fax details have changed. The new Analytica contact details are: Phone: (07) 3278 1950, Fax: (07) 3259 8313, Web: www.analyticamedical.com
-
Form 604
4 March 2008
Notice of change of interests of substantial holder - Viralytics Limited
-
Correction To Appendix 3B
29 February 2008
Analytica Limited (ASX:ALT) has become aware that the Appendix 3B lodged on 27 February contains typographical errors. A revised Appendix 3B is attached.
-
Appendix 3B
27 February 2008
New issue announcement, application for quotation of additional securities and agreement.
-
Appendix 4D - Half-Year Report
22 February 2008
Half Year Report for the 6 months ended December 2007 (current period) and the previous corresponding period 6 months ended 31 December 2006
-
Company Update
19 February 2008
Appointment of Regional Sales Manager and New Corporate Internet Domain
-
Form 604
8 February 2008
Notice of change of interests of substantial holder - Viralytics Limited
-
Appointment of Marketing and Sales Manager
4 February 2008
Analytica is pleased to announce the recruitment of Mrs Diana Seeney as Manager of Marketing and Sales.
-
Appendix 4C and Company Update
29 January 2008
Analytica presents its Appendix 4C for the quarter ended 31 December 2007 and an update on developments in the Company.
-
Appendix 3Y - Change of Director?s Interest Notice
22 January 2008
-
Form 604
18 January 2008
Notice of change of interests of substantial holder - Viralytics Limited
-
TGA Approval Received For Range Of Medical Devices
14 January 2008
Analytica is pleased to announce the inclusion of its Joint Venture burette, infusion set, and hypodermic needle products in the Australian Register of Therapeutic Goods (ARTG). Of particular note is that Analytica's Autostart Burette is also covered by this approval, contingent on successful completion of the current validation programme.
-
Form 604
11 January 2008
Notice of change of interests of substantial holder - Viralytics Limited
-
Form 604
4 January 2008
Notice of change of interests of substantial holder - Viralytics Ltd.
-
TGA Submissions Lodged
4 January 2008
Analytica is pleased to announce that it has lodged submissions with the TGA for regulatory approval of a number of medical devices. In particular, approvals for the burette family of products will include Analytica's Autostart Burette, pending successful completion of the validation programme.
